| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 19.7 | 12.3 | 22.8 | 14.9 | 5.9 | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.9 | 1.9 | 1.9 | 2.5 | 1.9 | ||
| 21.6 | 14.1 | 24.6 | 17.4 | 7.8 | ||
Expenses | ||||||
| 0.8 | 0.7 | 0.6 | 0.5 | 1.3 | ||
| 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| 1.7 | 1.3 | 5.6 | 3.9 | 3.1 | ||
| 2.5 | 2.1 | 6.2 | 4.4 | 4.4 | ||
| 17.2 | 10.2 | 16.6 | 10.6 | 1.5 | ||
| 17.2 | 10.2 | 16.6 | 10.6 | 1.5 | ||
Profit | ||||||
| 19.1 | 12.0 | 18.4 | 13.0 | 3.4 | ||
| 19.1 | 12.0 | 18.4 | 13.0 | 3.4 | ||
| 14.6 | 13.2 | 10.1 | 7.6 | 3.5 | ||
| −0.0 | 0.0 | 4.8 | 1.8 | −7.0 | ||
| 14.6 | 13.2 | 15.0 | 9.4 | −3.5 | ||
| 247 | 217 | 255 | 181 | 222 | ||
| 252 | 216 | 258 | 185 | 228 | ||
| 4.5 | −1.2 | 3.5 | 3.7 | 6.9 | ||
| 16.3 | 7.8 | −15.6 | 14.1 | 78.0 | ||
| 268 | 224 | 242 | 199 | 306 | ||
| — | 216 | 258 | 185 | 228 | ||
Per share | ||||||
| ₹788.02 | ₹676.83 | ₹808.40 | ₹579.28 | ₹715.75 | ||
| ₹788.02 | ₹676.83 | ₹808.40 | ₹579.28 | ₹715.75 | ||
Revenue detail — as filed | ||||||
| 3.4 | 3.4 | 2.3 | 2.3 | 1.9 | ||
| 15.6 | 8.2 | 19.3 | 11.6 | 0.6 | ||
Other comprehensive income — detail | ||||||
| 16.3 | 7.8 | −15.6 | 14.1 | 78.0 | ||
| 18.4 | 9.1 | −13.3 | 15.7 | 88.3 | ||
| 2.1 | 1.3 | 2.3 | — | — | ||
| — | — | — | 1.7 | 10.2 | ||
Per share — as-filed variants | ||||||
| ₹788.02 | ₹676.83 | ₹808.40 | ₹579.28 | ₹715.75 | ||
| ₹788.02 | ₹676.83 | ₹808.40 | ₹579.28 | ₹715.75 | ||
Adjusted (ex-exceptional items) — derived | ||||||
| 19.1 | 12.0 | 18.4 | 13.0 | 3.4 | ||
| 252 | 216 | 258 | 185 | 228 | ||
| ₹788.02 | ₹676.83 | ₹808.40 | ₹579.28 | ₹715.75 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 5.9 | 14.9 | 22.8 | 12.3 | 19.7 | |
| Other Income | 1.9 | 2.5 | 1.9 | 1.9 | 1.9 | |
| Total Income | 7.8 | 17.4 | 24.6 | 14.1 | 21.6 | |
| Expenses | ||||||
| + Employee Benefit Expense | 1.3 | 0.5 | 0.6 | 0.7 | 0.8 | |
| + Finance Costs | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| + Depreciation & Amortisation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | 3.1 | 3.9 | 5.6 | 1.3 | 1.7 | |
| Total Expenses | 4.4 | 4.4 | 6.2 | 2.1 | 2.5 | |
| EBITDA | 1.5 | 10.6 | 16.6 | 10.2 | 17.2 | |
| EBIT | 1.5 | 10.6 | 16.6 | 10.2 | 17.2 | |
| Profit | ||||||
| PBT before Exceptional Items | 3.4 | 13.0 | 18.4 | 12.0 | 19.1 | |
| Pretax Income | 3.4 | 13.0 | 18.4 | 12.0 | 19.1 | |
| + Current Tax | 3.5 | 7.6 | 10.1 | 13.2 | 14.6 | |
| + Deferred Tax | -7.0 | 1.8 | 4.8 | 0.0 | -0.0 | |
| Tax Expense | -3.5 | 9.4 | 15.0 | 13.2 | 14.6 | |
| + Share of Associates & JVs | 221.5 | 181.2 | 254.5 | 217.2 | 247.1 | |
| Net Income | 228.4 | 184.9 | 258.0 | 216.0 | 251.5 | |
| + Net Income — Continuing Ops | 6.9 | 3.7 | 3.5 | -1.2 | 4.5 | |
| + Other Comprehensive Income | 78.0 | 14.1 | -15.6 | 7.8 | 16.3 | |
| Total Comprehensive Income | 306.5 | 198.9 | 242.4 | 223.8 | 267.8 | |
| Net Income to Common | 228.4 | 184.9 | 258.0 | 216.0 | — | |
| Per Share | ||||||
| Basic EPS | 715.75 | 579.28 | 808.40 | 676.83 | 788.02 | |
| Diluted EPS | 715.75 | 579.28 | 808.40 | 676.83 | 788.02 | |
| Revenue Detail — as filed | ||||||
| + Dividend Income | 1.9 | 2.3 | 2.3 | 3.4 | 3.4 | |
| + Net Gain on Fair Value Changes | 0.6 | 11.6 | 19.3 | 8.2 | 15.6 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | 78.0 | 14.1 | -15.6 | 7.8 | 16.3 | |
| + Items NOT to be Reclassified to P&L | 88.3 | 15.7 | -13.3 | 9.1 | 18.4 | |
| + Tax on Items NOT to be Reclassified | — | — | 2.3 | 1.3 | 2.1 | |
| + Tax on Items NOT to be Reclassified — alt tag | 10.2 | 1.7 | — | — | — | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | 715.75 | 579.28 | 808.40 | 676.83 | 788.02 | |
| Diluted EPS — Continuing Operations | 715.75 | 579.28 | 808.40 | 676.83 | 788.02 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | 3.4 | 13.0 | 18.4 | 12.0 | 19.1 | |
| Net Income Adj (tax-effected) | 228.4 | 184.9 | 258.0 | 216.0 | 251.5 | |
| EPS Adj | 715.75 | 579.28 | 808.40 | 676.83 | 788.02 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Interest Earned | 3.4 | 1.0 | 1.2 | 0.6 | 0.7 | |
| Paid Up Equity Capital | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | |